Search
Elmustine
go.drugbank.com/drugs/DB20979ExperimentalElmustine has a monoisotopic molecular weight of 195.04 Da. … The usage of the INN stem '-mustine' in the name indicates that Elmustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Fenaperone
go.drugbank.com/drugs/DB21281ExperimentalFenaperone has a monoisotopic molecular weight of 376.22 Da. … The usage of the INN stem '-perone' in the name indicates that Fenaperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Metrenperone
go.drugbank.com/drugs/DB21312ExperimentalMetrenperone has a monoisotopic molecular weight of 407.2 Da. … The usage of the INN stem '-perone' in the name indicates that Metrenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Acefylline clofibrol
go.drugbank.com/drugs/DB21353ExperimentalThe usage of the INN stem '-fylline' in the name indicates that Acefylline clofibrol is a N-methylated xanthine derivative. Acefylline clofibrol has a monoisotopic molecular weight of 420.12 Da.
Nelutroctiv
go.drugbank.com/drugs/DB21554InvestigationalNelutroctiv has a monoisotopic molecular weight of 543.13 Da. … Nelutroctiv is under investigation in clinical trial NCT05662215 (A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants).
Sofnobrutinib
go.drugbank.com/drugs/DB21626ExperimentalSofnobrutinib has a monoisotopic molecular weight of 498.19 Da. … The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.
Lacutoclax
go.drugbank.com/drugs/DB21657InvestigationalThe usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Lacutoclax has a monoisotopic molecular weight of 922.36 Da.
Vilzemetkib
go.drugbank.com/drugs/DB21704ExperimentalVilzemetkib has a monoisotopic molecular weight of 642.27 Da. … The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.
R1295
go.drugbank.com/drugs/DB05122ExperimentalR1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. … Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Debamestrocel
go.drugbank.com/drugs/DB17934InvestigationalDebamestrocel consists of autologous mesenchymal stromal cells secreting neurotrophic factors. … Debamestrocel is under clinical development by BrainStorm Cell Therapeutics and is being investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS).[L47266]